Related Experiment Video
Updated: Aug 18, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Rhodamine-123 as effective agent in rat prostate tumor R3327-H. Preliminary report
Abstract:
Rhodamine-123 is a fluorescent dye that preferentially stains mitochondria and causes damage to mitochondria of malignant cells. The effect of this mitochondriacide on the transplantable rat prostate tumor R3327-H was determined in this study. Rhodamine was administered subcutaneously every other day at a dosage of 15 mg/Kg body weight for fifty-two days. There was significant alteration of the acinar cells with disruption of the cells from the basement membrane, as well as vacuolization and change in fibroblast shape and density. Rhodamine-123 may have a role in the treatment of prostatic cancer.

